Denver, Colorado, Nov. 20, 2014 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTCQB; FWDG), a leading provider of advanced
technologies and solutions to the global cannabis industry,
announces today that it is depositing 20,000,000 shares of common
stock of CB Scientific, Inc. ("CB Scientific") with a trust formed
for the benefit of holders of FutureWorld' common stock. CB
Scientific (http://www.cbscientific.com) is a wholly owned
subsidiary of FutureWorld based in Denver Colorado. CB Scientific
is continuing to develop new technologies specifically for cannabis
analytics and has always strived to help patients know exactly what
they are buying. CB Scientific believes every product sold to
patients as "Medical Quality" should be inspected for health
benefits, safety, consistency, purity, potency and packaged
properly for distribution.
The 20,000,000 CB Scientific shares initially will be held by an
independent trustee, subject to irrevocable instructions to
distribute 5,000,000 of those shares to FutureWorld shareholders of
record as of January 1, 2015, February 1, 2015, March 1, 2015 and
April 1, 2015. The distributions will be made when the CB
Scientific shares could be sold by the holders pursuant to an
effective registration statement filed with the Securities and
Exchange Commission or an exemption from such registration, which
currently is targeted to occur in the beginning of 2015.
As part of the above strategy, CB Scientific is planning to file
for an initial public offering of its common stock shortly after
the company has reached a sales threshold of 20,000 test kits per
month. CB Scientific currently is targeting the filing for
the beginning of 2015, subject to market and general economic
conditions as well as compliance with applicable securities laws.
FutureWorld will continue to beneficially own an additional
20,000,000 shares of CB Scientific common stock as a long-term
investment.
CB Scientific recently launched affordable PersonalAnalytics
Cannabis THC & CBD test kits. PersonalAnalytics test kits are
the world's first ever affordable home testing kits for potency of
cannabis cannabinoids (THC & CBD). The Company holds three
provisional patens and more to be filed in the near
future.
Now, anyone anywhere in the world can affordably have a quick
and accurate test to see the relative potency levels of their
cannabis medicine. CB Scientific is putting power in the hands of
patients worldwide who need to use medical cannabis and
hemp-related products such as CBD oil. In Colorado, California and
Washington, caregivers are now able to get affordable and
high-quality test results in 10 minutes or less. Patients in any
other state or country also now have the opportunity to know what
is in their medicine and its potency level without the high costs
of an outside laboratory. PersonalAnalytics THC & CBD: Simple,
Easy, Accurate, and Affordable!
Both THC and CBD home testing kits are already available at
several outlets in Spokane, Washington, Denver, Colorado and Los
Angeles, California including head shops, dispensaries and grow
stores. The kits are also available for purchase worldwide online
at cbscientific.com.
About CB Scientific
CB Scientific (http://www.cbscientific.com) is a wholly owned
Florida company based in Denver Colorado. CB Scientific is
continuing to develop new technologies specifically for cannabis
analytics. Senior management team are some of the primary men
advancing gas chromatography testing in Colorado. CB Scientific
believes every product sold to patients as "Medical Quality" should
be inspected for health benefits, safety, consistency, purity,
potency and packaged properly for distribution.
Senior management team of CB Scientific have worked with many of
the cannabis industry leaders in Colorado and have also been
featured in cannabis industry publications including High Times
Magazine, many trade publications, on-air interviews and panel
discussions across the United States. CB Scientific's focus has
been the education and safety of consumers combined with innovation
to put power into the hands of the patients. Values that
FutureWorld is pleased to embrace while ever striving to raise the
bar of cannabis analytics even higher.
About FutureWorld Corp
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a
U.S. Diversified Holding Company formed to capitalize on the
burgeoning Cannabis markets globally. FutureWorld, together with
its subsidiaries, focuses on the identification, acquisition,
development, and commercialization of cannabis related products,
such as industrial Hemp. FutureWorld, through its subsidiaries such
as HempTech and CB Scientific, provides personal and professional
THC and CBD test kits, pure CBD oil solutions, smart sensor
technology, communication network, surveillance security, data
analysis for smart cultivation and consultation for the industrial
hemp and legal medicinal cannabis. Our wireless agricultural smart
sensor networks offer precision to the agriculture, irrigation
systems, and greenhouses for the global cannabis and hemp industry.
FutureWorld and its subsidiaries do not grow, distribute or sell
marijuana.
To request further information about FutureWorld, please email
us at investors@futureworldcorp.com, log onto our website at
http://www.futureworldcorp.com or visit us at our Facebook page
https://www.facebook.com/futureworldenergy or on Twitter
#futureworldinc.
Forward-Looking Statements
This press release may contain forward-looking statements
covered within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements relate to,
among other things, plans and timing for the introduction or
enhancement of our services and products, statements about future
market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release
that are not historical fact and involve risks and uncertainties.
Our expectations regarding future revenues depend upon our ability
to develop and supply products and services that we may not produce
today and that meet defined specifications. When used in this press
release, the words "plan," "expect," "believe," and similar
expressions generally identify forward-looking statements. These
statements reflect our current expectations. They are subject to a
number of risks and uncertainties, including, but not limited to,
changes in technology and changes in pervasive markets. This
release includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that
are not historical facts may be deemed to be forward-looking
statements. Investors are cautioned that forward-looking statements
are inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approval for
anticipated actions.
CONTACT: Media Contact
FutureWorld Corp.
Http://www.futureworldcorp.com
Investor Relations
info@futureworldcorp.com
cox@futureworldcorp.com
(727) 474-1816 ext. 103
